William Martin
Directeur des opérations chez EpiVax, Inc.
Profil
William Martin is currently the Director at Epivax Oncology, Inc. and the Chief Operating & Information Officer at EpiVax, Inc. He previously worked as the Manager-Clinical Data & Database Architect at PAREXEL International Corp.
and Abt Associates, Inc.
Postes actifs de William Martin
| Sociétés | Poste | Début |
|---|---|---|
EpiVax, Inc.
 EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Directeur des opérations | 01/01/1998 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Anciens postes connus de William Martin
| Sociétés | Poste | Fin |
|---|---|---|
Abt Associates, Inc.
 Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Abt Associates, Inc. provides research and consulting services. It offers greenhouse gas emissions mitigation, low-emission development strategies, environmental research, air quality regulatory support, decision-support tools and IT solutions, ecological risk assessment, economic and regulatory analysis, value chain development, housing policies and programs, health systems strengthening, and workforce development. The company was founded by Clark Abt on January 12, 1965 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Abt Associates, Inc.
Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Abt Associates, Inc. provides research and consulting services. It offers greenhouse gas emissions mitigation, low-emission development strategies, environmental research, air quality regulatory support, decision-support tools and IT solutions, ecological risk assessment, economic and regulatory analysis, value chain development, housing policies and programs, health systems strengthening, and workforce development. The company was founded by Clark Abt on January 12, 1965 and is headquartered in Cambridge, MA. | Commercial Services |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
